Aytu Biopharma (AYTU) EBIT Margin (2013 - 2026)
Aytu Biopharma (AYTU) posted quarterly EBIT Margin of 32.75% for Q1 2026, down 4587.0% year-over-year from 0.73% in Q1 2025, and down 152.07% quarter-over-quarter from 12.99% in Q4 2025.
Aytu Biopharma (AYTU) EBIT Margin (2013 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported EBIT Margin for 14 consecutive years, with 32.75% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBIT Margin fell 4587.0% year-over-year to 32.75%; the TTM figure through Mar 2026 stood at 26.79% (down 2302.0% YoY), while the FY2025 annual figure was 11.79%, down 935.0% from the prior year.
- EBIT Margin declined to 32.75% in Q1 2026 per AYTU's latest filing, from 12.99% in the prior quarter.
- Across five years, EBIT Margin topped out at 16.78% in Q4 2023 and bottomed at 220.76% in Q1 2022.
- Historically, EBIT Margin has averaged 28.07% across 5 years, with a median of 11.39% in 2024.
- Annual changes were most pronounced in 2023 — EBIT Margin soared 18311 bps — and 2026, when it slumped 4587 bps.
- Aytu Biopharma's EBIT Margin stood at 26.13% in 2022, then surged by 164 bps to 16.78% in 2023, then sank by 162 bps to 10.45% in 2024, then dropped by 24 bps to 12.99% in 2025, then plunged by 152 bps to 32.75% in 2026.
- Business Quant data shows AYTU's EBIT Margin at 32.75% in Q1 2026, 12.99% in Q4 2025, and 10.83% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Aytu Biopharma | 24.81 Mn | -1.91 Mn | 7.60 Mn | -32.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.75% |
| Dec 31, 2025 | -12.99% |
| Sep 30, 2025 | -10.83% |
| Jun 30, 2025 | -50.37% |
| Mar 31, 2025 | 13.12% |
| Dec 31, 2024 | -10.45% |
| Sep 30, 2024 | -5.61% |
| Jun 30, 2024 | -15.58% |
| Mar 31, 2024 | -11.39% |
| Dec 31, 2023 | 16.78% |
| Sep 30, 2023 | -4.87% |
| Jun 30, 2023 | 0.55% |
| Mar 31, 2023 | -37.65% |
| Dec 31, 2022 | -26.13% |
| Sep 30, 2022 | -6.54% |
| Jun 30, 2022 | -61.72% |
| Mar 31, 2022 | -220.76% |
| Dec 31, 2021 | -48.84% |
| Sep 30, 2021 | -126.50% |
| Jun 30, 2021 | -102.51% |